NPPB and hydrops fetalis: ROC curve analysis revealed that LVEF < 40% (Figure 2A), serum irisin < 6.50 ng/ml (Figure 2B) and NT-proBNP > 2,250 pmol/ml (Figure 2C) were reliable models for predicting CV composite outcomes in HF patients with T2DM.